, Volume 13, Issue 2, pp 182–196 | Cite as

Biological activity of the e domain of the IGF-1Ec as addressed by synthetic peptides

  • George Vassilakos
  • Anastassios Philippou
  • Panagiotis Tsakiroglou
  • Michael KoutsilierisEmail author


Insulin-like growth factor-1 (IGF-1) is a multipotent growth factor involved in the growth, development and regulation of homeostasis in a tissue-specific manner. Alternative splicing, multiple transcription initiation sites and different polyadelynation signals give rise to diverse mRNA isoforms, such as IGF-1Ea, IGF-1Eb and IGF-1Ec transcripts. There is increasing interest in the expression of the IGF-1 isoforms and their potential distinct biological role. IGF-1Ec results from alternative splicing of exons 4-5-6 and its expression is upregulated in various conditions and pathologies. Recent studies have shown that IGF-1Ec is preferentially increased after injury in skeletal muscle during post-infarctal myocardium remodelling and in cancer tissues and cell lines. A synthetic analogue corresponding to the last 24 aa of the E domain of the IGF-1Ec isoform has been used to elucidate its potential biological role. The aim of the present review is to describe and discuss the putative bioactivity of the E domain of the IGF-1Ec isoform.

Key words

E peptides Human cells IGF-1Ec 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jones JI, Clemmons DR, 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3–34.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Kooijman R, 2006 Regulation of apoptosis by insulinlike growth factor (IGF)-I. Cytokine Growth Factor Rev 17: 305–323.CrossRefPubMedGoogle Scholar
  3. 3.
    Frystyk J, Freda P, Clemmons DR, 2010 The current status of IGF-I assays—a 2009 update. Growth Horm IGF Res 20: 8–18.CrossRefPubMedGoogle Scholar
  4. 4.
    Dupont J, Le Roith D, 2001 Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Mol Pathol 54: 149–154.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kofidis T, de Bruin JL, Yamane T, et al, 2004 Insulinlike growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 22: 1239–1245.CrossRefPubMedGoogle Scholar
  6. 6.
    Siddle K, Urso B, Niesler CA, et al, 2001 Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochem Soc Trans 29: 513–525.CrossRefPubMedGoogle Scholar
  7. 7.
    Baserga R, Peruzzi F, Reiss K, 2003 The IGF-1 receptor in cancer biology. Int J Cancer 107: 873–877.CrossRefPubMedGoogle Scholar
  8. 8.
    Laviola L, Natalicchio A, Giorgino F, 2007 The IGF-I signaling pathway. Curr Pharm Des 13: 663–669.CrossRefPubMedGoogle Scholar
  9. 9.
    Kim SW, Lajara R, Rotwein P, 1991 Structure and function of a human insulin-like growth factor-I gene promoter. Mol Endocrinol 5: 1964–1972.CrossRefPubMedGoogle Scholar
  10. 10.
    Wallis M, 2009 New insulin-like growth factor (IGF)-precursor sequences from mammalian genomes: the molecular evolution of IGFs and associated peptides in primates. Growth Horm IGF Res 19: 12–23.CrossRefPubMedGoogle Scholar
  11. 11.
    Adamo ML, Ben-Hur H, LeRoith D, Roberts CT Jr, 1991 Transcription initiation in the two leader exons of the rat IGF-I gene occurs from disperse versus localized sites. Biochem Biophys Res Commun 176: 887–893.CrossRefPubMedGoogle Scholar
  12. 12.
    Simmons JG, Van Wyk JJ, Hoyt EC, Lund PK, 1993 Multiple transcription start sites in the rat insulin-like growth factor-I gene give rise to IGF-I mRNAs that encode different IGF-I precursors and are processed differently in vitro. Growth Factors 9: 205–221.CrossRefPubMedGoogle Scholar
  13. 13.
    Yang H, Adamo ML, Koval AP, et al, 1995 Alternative leader sequences in insulin-like growth factor I mRNAs modulate translational efficiency and encode multiple signal peptides. Mol Endocrinol 9: 1380–1395.PubMedGoogle Scholar
  14. 14.
    Rotwein P, 1991 Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 5: 3–18.CrossRefPubMedGoogle Scholar
  15. 15.
    Chew SL, Lavender P, Clark AJ, Ross RJ, 1995 An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. Endocrinology 136: 1939–1944.CrossRefPubMedGoogle Scholar
  16. 16.
    Shimatsu A, Rotwein P, 1987 Mosaic evolution of the insulin-like growth factors. Organization, sequence, and expression of the rat insulin-like growth factor I gene. J Biol Chem 262: 7894–7900.PubMedGoogle Scholar
  17. 17.
    Jansen M, van Schaik FM, Ricker AT, et al, 1983 Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature 306: 609–611.CrossRefPubMedGoogle Scholar
  18. 18.
    Lund PK, Hoyt EC, Van Wyk JJ, 1989 The size heterogeneity of rat insulin-like growth factor-I mRNAs is due primarily to differences in the length of 3′-untranslated sequence. Mol Endocrinol 3: 2054–2061.CrossRefPubMedGoogle Scholar
  19. 19.
    Duguay SJ, 1999 Post-translational processing of insulinlike growth factors. Horm Metab Res 31: 43–49.CrossRefPubMedGoogle Scholar
  20. 20.
    Hall LJ, Kajimoto Y, Bicheil D, et al, 1992 Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter. DNA Cell Biol 11: 301–313.CrossRefPubMedGoogle Scholar
  21. 21.
    Wang X, Yang Y, Adamo ML, 1997 Characterization of the rat insulin-like growth factor I gene promoters and identification of a minimal exon 2 promoter. Endocrinology 138: 1528–1536.CrossRefPubMedGoogle Scholar
  22. 22.
    Rotwein P, 1986 Two insulin-like growth factor I messenger RNAs are expressed in human liver. Proc Natl Acad Sci USA 83: 77–81.CrossRefPubMedGoogle Scholar
  23. 23.
    Barton ER, 2006 The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair. Appl Physiol Nutr Metab 31: 791–797.CrossRefPubMedGoogle Scholar
  24. 24.
    Zhang J, Yang R, Sun S, et al, 2013 Cloning and characterization of new transcript variants of insulin-like growth factor-I in Sika deer (Cervus elaphus). Growth Horm IGF Res 23: 120–127.CrossRefPubMedGoogle Scholar
  25. 25.
    Philippou A, Halapas A, Maridaki M, Koutsilieris M, 2007 Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J Musculoskelet Neuronal Interact 7: 208–218.PubMedGoogle Scholar
  26. 26.
    Rotwein P, Bicheil DP, Kikuchi K, 1993 Multifactorial regulation of IGF-I gene expression. Mol Reprod Dev 35: 358–363.CrossRefPubMedGoogle Scholar
  27. 27.
    O’Sullivan DC, Szestak TA, Pell JM, 2002 Regulation of IGF-I mRNA by GH: putative functions for class 1 and 2 message. Am J Physiol Endocrinol Metab 283: 251–258.CrossRefGoogle Scholar
  28. 28.
    Shemer J, Adamo ML, Roberts CT Jr, LeRoith D, 1992 Tissue-specific transcription start site usage in the leader exons of the rat insulin-like growth factor-I gene: evidence for differential regulation in the developing kidney. Endocrinology 131: 2793–2799.CrossRefPubMedGoogle Scholar
  29. 29.
    Jansen E, Steenbergh PH, van Schaik FM, Sussenbach JS, 1992 The human IGF-I gene contains two cell type-specifically regulated promoters. Biochem Biophys Res Commun 187: 1219–1226.CrossRefPubMedGoogle Scholar
  30. 30.
    Stewart CE, Rotwein P, 1996 Growth, differentiation, and survival: multiple physiological functions for insulinlike growth factors. Physiol Rev 76: 1005–1026.CrossRefPubMedGoogle Scholar
  31. 31.
    Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SD, 2003 Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol 547: 247–254.CrossRefPubMedGoogle Scholar
  32. 32.
    Siegfried JM, Kasprzyk PG, Treston AM, Mulshine JL, Quinn KA, Cuttitta F, 1992 A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc Natl Acad Sci USA 89: 8107–8111.CrossRefPubMedGoogle Scholar
  33. 33.
    Lee EK, Gorospe M, 2010 Minireview: posttranscriptional regulation of the insulin and insulin-like growth factor systems. Endocrinology 151: 1403–1408.CrossRefPubMedGoogle Scholar
  34. 34.
    Winter J, Jung S, Keller S, Gregory RI, Diederichs S, 2009 Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11: 228–234.CrossRefPubMedGoogle Scholar
  35. 35.
    Xie X, Lu J, Kulbokas EJ, et al, 2005 Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434: 338–345.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Elia L, Contu R, Quintavalle M, et al, 2009 Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120: 2377–2385.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Yu XY, Song YH, Geng YJ, et al, 2008 Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochem Biophys Res Commun 376: 548–552.CrossRefPubMedGoogle Scholar
  38. 38.
    Shan ZX, Lin QX, Fu YH, et al, 2009 Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun 381: 597–601.CrossRefPubMedGoogle Scholar
  39. 39.
    Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM, 2009 MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36: 181–188.CrossRefPubMedGoogle Scholar
  40. 40.
    Yan B, Zhu CD, Guo JT, Zhao LH, Zhao JL, 2013 miR-206 regulates the growth of the teleost tilapia (Oreochromis niloticus) through the modulation of IGF-1 gene expression. J Exp Biol 216: 1265–1269.CrossRefPubMedGoogle Scholar
  41. 41.
    Duguay SJ, Lai-Zhang J, Steiner DF, 1995 Mutational analysis of the insulin-like growth factor I prohormone processing site. J Biol Chem 270: 17566–17574.CrossRefPubMedGoogle Scholar
  42. 42.
    Philippou A, Maridaki M, Halapas A, Koutsilieris M, 2007 The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo 21: 45–54.PubMedGoogle Scholar
  43. 43.
    Shavlakadze T, Winn N, Rosenthal N, Grounds MD, 2005 Reconciling data from transgenic mice that over-express IGF-I specifically in skeletal muscle. Growth Horm IGF Res 15: 4–18.CrossRefPubMedGoogle Scholar
  44. 44.
    Philippou A, Armakolas A, Koutsilieris M, 2013 Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer. Front Endocrinol (Lausanne) 4: 31.Google Scholar
  45. 45.
    Magee BA, Shooter GK, Wallace JC, Francis GL, 1999 Insulin-like growth factor I and its binding proteins: a study of the binding interface using B-domain analogues. Biochemistry 38: 15863–15870.CrossRefPubMedGoogle Scholar
  46. 46.
    Gauguin L, Klaproth B, Sajid W, et al, 2008 Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor. J Biol Chem 283: 2604–2613.CrossRefPubMedGoogle Scholar
  47. 47.
    Sara VR, Carlsson-Skwirut C, Bergman T, et al, 1989 Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide. Biochem Biophys Res Commun 165: 766–771.CrossRefPubMedGoogle Scholar
  48. 48.
    Sara VR, Carlsson-Skwirut C, Drakenberg K, et al, 1993 The biological role of truncated insulin-like growth factor-1 and the tripeptide GPE in the central nervous system. Ann NY Acad Sci 692: 183–191.CrossRefPubMedGoogle Scholar
  49. 49.
    Durzynska J, Wardzinski A, Koczorowska M, Gozdzicka-Jozefiak A, Barton ER, 2013 Human Eb Peptide: Not just a By-product of Pre-pro-IGF lb Processing? Horm Metab Res 6: 415–22.Google Scholar
  50. 50.
    Yang S, Alnaqeeb M, Simpson H, Goldspink G, 1996 Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil 17: 487–495.CrossRefPubMedGoogle Scholar
  51. 51.
    Durzynska J, Philippou A, Brisson BK, Nguyen-McCarty M, Barton ER, 2013 The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation. Endocrinology 154: 1215–1224.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Dai Z, Wu F, Yeung EW, Li Y, 2010 IGF-1Ec expression, regulation and biological function in different tissues. Growth Horm IGF Res 20: 275–281.CrossRefPubMedGoogle Scholar
  53. 53.
    Philippou A, Papageorgiou E, Bogdanis G, et al, 2009 Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. In Vivo 23: 567–575.PubMedGoogle Scholar
  54. 54.
    Greig CA, Hameed M, Young A, Goldspink G, Noble B, 2006 Skeletal muscle IGF-I isoform expression in healthy women after isometric exercise. Growth Horm IGF Res 16: 373–376.CrossRefPubMedGoogle Scholar
  55. 55.
    Cortes E, te Fong LF, Hameed M, et al, 2005 Insulinlike growth factor-1 gene splice variants as markers of muscle damage in levator ani muscle after the first vaginal delivery. Am J Obstet Gynecol 193: 64–70.CrossRefPubMedGoogle Scholar
  56. 56.
    Hameed M, Lange KH, Andersen JL, et al, 2004 The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol 555: 231–240.CrossRefPubMedGoogle Scholar
  57. 57.
    McKoy G, Ashley W, Mander J, et al, 1999 Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol 516: 583–592.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Stavropoulou A, Halapas A, Sourla A, et al, 2009 IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro. Mol Med 15: 127–135.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Tang LL, Xian CY, Wang YL, 2006 The MGF expression of osteoblasts in response to mechanical overload. Arch Oral Biol 51: 1080–1085.CrossRefPubMedGoogle Scholar
  60. 60.
    Hill M, Goldspink G, 2003 Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol 549: 409–418.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Brisson BK, Barton ER, 2012 Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor. PLoS One 7: e45588.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Matheny RW Jr, Nindl BC, 2011 Loss of IGF-IEa or IGF-IEb impairs myogenic differentiation. Endocrinology 152: 1923–1934.CrossRefPubMedGoogle Scholar
  63. 63.
    Koczorowska MM, Kwasniewska A, Gozdzicka-Jozefiak A, 2011 IGF 1 mRNA isoform expression in the cervix of HPV-positive women with pre-cancerous and cancer lesions. Exp Ther Med 2: 149–156.CrossRefPubMedGoogle Scholar
  64. 64.
    Kasprzak A, Szaflarski W, Szmeja J, et al, 2012 Expression of various insulin-like growth factor-1 mRNA isoforms in colorectal cancer. Contemp Oncol (Pozn) 16: 147–153.Google Scholar
  65. 65.
    Milingos DS, Philippou A, Armakolas A, et al, 2011 Insulin like growth factor-1Ec (MGF) expression in eutopic and ectopic endometrium: characterization of the MGF E-peptide actions in vitro. Mol Med 17: 21–28.CrossRefPubMedGoogle Scholar
  66. 66.
    Armakolas A, Philippou A, Panteleakou Z, et al, 2010 Preferential expression of IGF-1Ec (MGF) transcript in cancerous tissues of human prostate: evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells. Prostate 70: 1233–1242.CrossRefPubMedGoogle Scholar
  67. 67.
    Philippou A, Armakolas A, Panteleakou Z, et al, 2011 IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma cells. Anticancer Research 31: 4259–4265.PubMedGoogle Scholar
  68. 68.
    Kuo YH, Chen TT, 2002 Novel activities of pro-IGF-I E peptides: regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells. Exp Cell Res 280: 75–89.CrossRefPubMedGoogle Scholar
  69. 69.
    Kuo YH, Chen TT, 2003 Specific cell surface binding sites shared by human Pro-IGF-I Eb-peptides and rainbow trout Pro-IGF-I Ea-4-peptide. Gen Comp Endocrinol 132: 231–240.CrossRefPubMedGoogle Scholar
  70. 70.
    Yang SY, Goldspink G, 2002 Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 522: 156–160.CrossRefPubMedGoogle Scholar
  71. 71.
    Mills P, Dominique JC, Lafreniere JF, Bouchentouf M, Tremblay JP, 2007 A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success. Am J Transplant 7: 2247–2259.CrossRefPubMedGoogle Scholar
  72. 72.
    Mills P, Lafreniere JF, Benabdallah BF, El Fahime LM, Tremblay JP, 2007 A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor. Exp Cell Res 3: 527–537.CrossRefGoogle Scholar
  73. 73.
    Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP, 1999 Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 274: 13066–13076.CrossRefPubMedGoogle Scholar
  74. 74.
    Ates K, Yang SY, Orrell RW, et al, 2007 The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle. FEBS Lett 581: 2727–2732.CrossRefPubMedGoogle Scholar
  75. 75.
    Dluzniewska J, Sarnowska A, Beresewicz M, et al, 2005 A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. Faseb J 19: 1896–1898.CrossRefPubMedGoogle Scholar
  76. 76.
    Carpenter V, Matthews K, Devlin G, et al, 2008 Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction. Heart Lung Circ 17: 33–39.CrossRefPubMedGoogle Scholar
  77. 77.
    Quesada A, Micevych P, Handforth A, 2009 C-terminal mechano growth factor protects dopamine neurons: a novel peptide that induces heme oxygenase-1. Exp Neurol 220: 255–266.CrossRefPubMedGoogle Scholar
  78. 78.
    Florini JR, Ewton DZ, Coolican SA, 1996 Growth hormone and the insulin-like growth factor system in myogenesis. Endocr rev 17: 481–517.PubMedGoogle Scholar
  79. 79.
    Samuel DS, Ewton DZ, Coolican SA, Petley TD, McWade FJ, Florini JR, 1999 Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts. Horm Metab Res 31: 55–64.CrossRefPubMedGoogle Scholar
  80. 80.
    Owino V, Yang SY, Goldspink G, 2001 Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett 505: 259–263.CrossRefPubMedGoogle Scholar
  81. 81.
    Kandalla PK, Goldspink G, Butler-Browne G, Mouly V, 2011 Mechano Growth Factor E peptide (MGF-E), derived from an isoform of IGF-1, activates human muscle progenitor cells and induces an increase in their fusion potential at different ages. Mech Ageing Dev 132: 154–162.CrossRefPubMedGoogle Scholar
  82. 82.
    Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S, 2008 Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 26: 2201–2210.CrossRefPubMedGoogle Scholar
  83. 83.
    Collins JM, Goldspink PH, Russell B, 2010 Migration and proliferation of human mesenchymal stem cells is stimulated by different regions of the mechano-growth factor prohormone. J Mol Cell Cardiol 49: 1042–1045.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Riedemann J, Macaulay VM, 2006 IGF1R signalling and its inhibition. Endocr Relat Cancer 13: Suppl 1: 33–43.CrossRefGoogle Scholar
  85. 85.
    Garcia-Echeverria C, Pearson MA, Marti A, et al, 2004 In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 5: 231–239.CrossRefPubMedGoogle Scholar
  86. 86.
    Cheng Y, Prusoff WH, 1973 Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099–3108.CrossRefPubMedGoogle Scholar
  87. 87.
    LeRoith D, Helman L, 2004 The new kid on the block(ade) of the IGF-1 receptor. Cancer Cell 5: 201–202.CrossRefPubMedGoogle Scholar
  88. 88.
    Navarro E, Alonso SJ, Martin FA, Castellano MA, 2005 Toxicological and pharmacological effects of D-arginine. Basic Clin Pharmacol Toxicol 97: 149–154.CrossRefPubMedGoogle Scholar
  89. 89.
    Veronese FM, 2001 Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22: 405–417.CrossRefPubMedGoogle Scholar
  90. 90.
    Harris JM, Chess RB, 2003 Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2: 214–221.CrossRefPubMedGoogle Scholar
  91. 91.
    Metzger F, Sajid W, Saenger S, et al, 2011 Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I). J Biol Chem 286: 19501–19510.CrossRefPubMedPubMedCentralGoogle Scholar
  92. 92.
    Hede MS, Salimova E, Piszczek A, et al, 2012 E-Peptides Control Bioavailability of IGF-1. PLoS One 7: e51152.CrossRefPubMedPubMedCentralGoogle Scholar
  93. 93.
    Philippou A, Stavropoulou A, Sourla A, et al, 2008 Characterization of a rabbit antihuman mechano growth factor (MGF) polyclonal antibody against the last 24 amino acids of the E domain. In Vivo 22: 27–35.PubMedGoogle Scholar
  94. 94.
    Kravchenko IV, Furalyov VA, Khotchenkov VP, Popov VO, 2006 Monoclonal antibodies to mechano-growth factor. Hybridoma (Larchmt) 25: 300–305.CrossRefGoogle Scholar
  95. 95.
    Torrado J, Carrascosa C, 2003 Pharmacological characteristics of parenteral IGF-I administration. Curr Pharm Biotechnol 4: 123–140.CrossRefPubMedGoogle Scholar
  96. 96.
    Buchanan CM, Phillips AR, Cooper GJ, 2001 Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochem J 360: 431–439.CrossRefPubMedPubMedCentralGoogle Scholar
  97. 97.
    Matheny RW Jr, Nindl BC, Adamo ML, 2010 Mini-review: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 151: 865–875.CrossRefPubMedPubMedCentralGoogle Scholar
  98. 98.
    Peng Q, Qiu J, Sun J, Yang L, Zhang B, Wang Y, 2012 The nuclear localization of MGF receptor in osteoblasts under mechanical stimulation. Mol Cell Biochem 369: 147–156.CrossRefPubMedGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2014

Authors and Affiliations

  • George Vassilakos
    • 1
  • Anastassios Philippou
    • 1
  • Panagiotis Tsakiroglou
    • 1
  • Michael Koutsilieris
    • 1
    Email author
  1. 1.Department of Experimental Physiology, Medical SchoolNational & Kapodistrian University of AthensGoudi-AthensGreece

Personalised recommendations